Information Technology · Services-Computer Processing & Data Preparation · Nasdaq · CIK 1809519 · FYE Dec 31 · Prices AT CLOSE 2026-08-21 (USD) Last $3.45 · Day −3.09% · Mkt cap $1.2B · P/E (FY) 38.3× · 1Y −23.2% · Off 52W high −40.6% · Vol (1Y) 61.5% Price2023-08-21 → 2026-08-21 GDRX close: $6.52 on 2023-08-21 to $3.45 on 2026-08-21. Split-adj closes · 240 of 1,377 · price returnⓘ At a glance | Short interest1.6% of sh out | | Days to cover5.4d | | 13F net flow (QoQ)+0.52% | | Top-10 13F concentration77.6% | | Next report (est.)2026-11-04 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | P/E (FY)38.3× | | Sales (TTM)$785.2M | | Earnings (TTM)$16.2M | | ROE4.5% | | Net margin3.8% | | ROIC5.8% | | Debt / equity0.79× | | Total debt / EBITDA2.83× | | Sales growth 3Y1.3% |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD+27.3% | | 1Y−23.2% | | 3Y−47.1% | | 5Y−89.9% | | Since incept. (ann.)−38.5% |
Total return · from 2021-02-22ⓘ Risk | Ann. volatility (1Y)61.5% | | Ann. volatility (3Y)64.7% | | Sharpe (1Y)−0.09 | | Sharpe (3Y)−0.01 | | Max drawdown (1Y)−62.8% | | Max drawdown (3Y)−79.3% | | Beta (3Y vs SPY)1.57 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| Francisco Partners Management, LP | 60.1M | $118M | 16.83% | +0.0% | | LSV ASSET MANAGEMENT | 5.0M | $10M | 1.40% | +76.3% | | AMERIPRISE FINANCIAL INC | 4.5M | $9M | 1.25% | +36.2% | | VANGUARD CAPITAL MANAGEMENT LLC | 4.3M | $8M | 1.19% | new | | Silver Lake Group, L.L.C. | 3.5M | $7M | 0.99% | +0.0% | | VANGUARD PORTFOLIO MANAGEMENT LLC | 3.4M | $7M | 0.94% | new | | RENAISSANCE TECHNOLOGIES LLC | 3.3M | $6M | 0.91% | +1.5% | | Petrus Trust Company, LTA | 3.1M | $6M | 0.87% | +0.0% |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-08-05 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-05 | $0.02 | −50.0% | $200.4M | −1.3% | | 2026-03-31 | 2026-05-06 | $0.00 | −100.0% | $194.0M | −4.4% | | 2025-12-31 | 2026-02-25 | — | — | $194.8M | −1.9% | | 2025-09-30 | 2025-11-04 | $0.00 | −100.0% | $196.0M | +0.4% |
As-reported XBRL · next 2026-11-04 est.ⓘ Segment mixFY2025 (ended Dec 2025) Prescription Transactions Revenue 68% · Pharma Direct Revenue 19% · Subscription Revenue 11% · Other Revenue 2% product & service · TAGGED revenueⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
| 
